Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
Instituto de Biomedicina de Sevilla · Carlo Forlanini Hospital · +12 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
613
total citations
- FWCI
- 63.89
- Percentile
- 100%
- References
- 35
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Pemetrexed
- Medicine
- Internal medicine
- Oncology
- Lung cancer
- Clinical endpoint
- Maintenance therapy
- Performance status
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.